Buy Amvuttra from Europe.
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name xxx originating from Europe is manufactured at the following site(s):Alnylam Netherlands B.V. Antonio Vivaldistraat 150 1083 HP Amsterdam Netherlands.
Information about Amvuttra (Vutrisiran):
- Amvuttra (Vutrisiran) is a medication primarily used for the treatment of a rare genetic disorder called hereditary transthyretin-mediated amyloidosis (hATTR
- This is a condition where abnormal amyloid proteins build up in various organs and tissues of the body, leading to damage and dysfunction.
- The medication is typically administered by healthcare professionals through intravenous (IV) infusion. The exact dosage and frequency of administration will be determined by your healthcare provider based on your individual condition and response to treatment.
Product Highlights
- Reduces the production of abnormal transthyretin protein, thereby slowing down the progression of the disease.
- Administered less frequently compared to some other treatments for hATTR.
- Vutrisiran, the active ingredient, is RNA interference (RNAi) therapeutic.
Key Ingredients
- Vutrisiran
- Sodium dihydrogen phosphate dihydrate
- Disodium phosphate dihydrate
- Sodium chloride and water for injections
Key Benefits
- Slows disease progression by reducing levels of abnormal transthyretin protein.
- Improves symptoms associated with hATTR, such as neuropathy and organ dysfunction.
Direction For Use
- The prescribed dosage of Amvuttra is 25 mg given as a subcutaneous injection every 3 months.
Safety Concern
- Like all medications, Amvuttra (Vutrisiran) may cause side effects. Common side effects include reactions at the infusion site, headaches, and fatigue.
- Serious allergic reactions are rare but possible. It's important to report any unusual symptoms or reactions to your healthcare provider promptly.
Avoid Taking Amvuttra (Vutrisiran) If:
- You should avoid taking Amvuttra (Vutrisiran) if you are allergic to any of its components.
- Not use Amvuttra if you are pregnant.
- Always inform your healthcare provider about any allergies or medical conditions you have before starting treatment.
